NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002322

Registered date:11/08/2009

Administration time-dependent effects of raloxifen in postmenopausal women with osteoporosis

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedpostmenopausal osteoporosis
Date of first enrollment2009/08/01
Target sample size64
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Morning-administration of raloxifene Evening-administration of raloxifene

Outcome(s)

Primary OutcomeCoagulation and fibrinolysis factors
Secondary OutcomeBone metabolism markers Adverse reactions Bone density

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderFemale
Include criteria
Exclude criteriaTreatment with raloxifene or bisphosphonate in the preceding 12 months Anticoagulant therapy Inpatients Current or previous venous thromboembolism Bedridden subjects Antiphospholipid antibody syndrome Possibility of pregnancy Hypersensitivity to raloxifene Severe hepatic impairment Severe renal dysfunction Other unsuitableness

Related Information

Contact

public contact
Name
Address Japan
Telephone
E-mail
Affiliation Jichi Medical University Clinical Pharmacology
scientific contact
Name Hitoshi Ando
Address 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan Japan
Telephone 0285-58-7388
E-mail
Affiliation Jichi Medical University Clinical Pharmacology